Abstract
Carboplatin (cis-diammine-1,1-cyclobutane-dicarboxylatoplatinum(II)) is the only cisplatin (cis-diammine-dichloroplatinum(II)) derivative currently available for the treatment of cancer worldwide. The higher stability of the carboxylate ligand compared to the coordinated chloride in cisplatin results in a reduced reactivity of the molecule. Capillary electrophoresis has been applied for investigating the adduct formation of carboplatin and analogues with nucleoside monophosphates, di- and trinucleotides. Adduct formation results in a significant shift of the absorption maximum to lower energy compared to free nucleotides. Therefore, characterization of the analytes was performed by UV additionally to NMR spectroscopy. A preference for GMP- and AMP-coordination was found. The ability of separating all four common nucleotides and their major platinum adducts in a single run demonstrates the suitability of CE for this kind of investigations. Copyright Œ 2001 Elsevier Science B.V.
| Original language | English |
|---|---|
| Pages (from-to) | 181-186 |
| Number of pages | 6 |
| Journal | Journal of Inorganic Biochemistry |
| Volume | 83 |
| Issue number | 2-3 |
| DOIs | |
| Publication status | Published - 2001 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Austrian Fields of Science 2012
- 1040 Chemistry
Fingerprint
Dive into the research topics of 'Capillary electrophoretic study of carboplatin and analogues with nucleoside monophosphates, di- and trinucleotides'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver